Drug Approval | January 22, 2025
Kwality Pharmaceuticals receives SFDA GMP approval for 2 units
This certification will open new markets for the Kwality Pharma
This certification will open new markets for the Kwality Pharma
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
According to IQVIATM sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market achieved annual sales of approximately $19.7 million
The Acetaminophen and Ibuprofen tablets will be manufactured at the company’s flagship facility in KRSG, Bengaluru
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
Jemperli plus chemotherapy is the only immuno-oncology-based treatment to show statistically significant and clinically meaningful OS benefit in the overall population
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
This study will enrol 210 ALS patients and study doses of 50 mg and 75 mg Usnoflast versus placebo
The change is reflective of the company’s evolving vision aimed at further strengthening its global presence and a commitment to providing innovative solutions in the API and CDMO space
This is the second Ready-To-Use Infusion bag (RTU Bags) ANDA drug product approved for Caplin Steriles
Subscribe To Our Newsletter & Stay Updated
